Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123142 | 0.97 | CYP3A4 (0.62) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL4712957 | 0.96 | CYP3A4 (0.57) | CYP3A4L3MBTL1TSHRCA2 | |
| SCHEMBL4711373 | 0.95 | CYP3A4 (0.56) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL4711504 | 0.92 | CYP3A4 (0.56) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| Octicizer SCHEMBL5666048 | 0.91 | CYP3A4 (0.55) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| Triphenyl Phosphate SCHEMBL9712107 | 0.91 | CYP3A4 (0.58) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL4710581 | 0.90 | CYP3A4 (0.54) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL10708754 | 0.90 | CYP3A4 (0.54) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| SCHEMBL31495240 | 0.89 | CYP3A4 (0.62) | CYP3A4L3MBTL1TSHRALDH1A1CA2 | |
| Chloromethane SCHEMBL27694337 | 0.87 | CYP3A4 (0.50) | CYP3A4L3MBTL1TSHRALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391838-B2 | Synergistic flame retardant compositions and fiber blends including the same | US GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2025-08-19 | — | — | US | claimed |
| US-20200056057-A1 | SYNERGISTIC FLAME RETARDANT COMPOSITIONS AND FIBER BLENDS INCLUDING THE SAME | THE UNIVERSITY OF MASSACHUSETTS | 2020-02-20 | — | — | US | claimed |
| EP-2906632-B1 | ANTISTATIC FLAME RETARDANT RESIN COMPOSITION AND METHODS AND USES THEREOF | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2018-03-21 | — | — | EP | claimed |
| US-9260602-B2 | Antistatic flame retardant resin compositions and methods and uses thereof | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-02-16 | — | — | US | claimed |
| EP-2906632-A1 | ANTISTATIC FLAME RETARDANT RESIN COMPOSITION AND METHODS AND USES THEREOF | SABIC Global Technologies B.V. (NL) | 2015-08-19 | — | — | EP | claimed |
| EP-2143764-A1 | Antistatic flame retardant resin composition and methods for manufacture thereof | Sabic Innovative Plastics IP B.V. (NL) | 2010-01-13 | — | — | EP | claimed |
| EP-1963419-A2 | POLYCARBONATE COMPOSITION, METHOD OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | General Electric Company (US) | 2008-09-03 | — | — | EP | claimed |
| WO-2007075780-A2 | POLYCARBONATE COMPOSITION, METHOD OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2007-07-05 | — | — | WO | claimed |
| US-7018567-B2 | For use in electrical and electronic equipment and precision machinery | GENERAL ELECTRIC COMPANY (US) | 2006-03-28 | — | — | US | claimed |
| EP-1539884-A1 | ANTISTATIC FLAME RETARDANT RESIN COMPOSITION AND METHODS FOR MANUFACTURE THEREOF | GENERAL ELECTRIC COMPANY (US) | 2005-06-15 | — | — | EP | claimed |
| EP-1185586-B1 | COMPOSITIONS WITH ENHANCED DUCTILITY | GEN ELECTRIC (US) | 2004-12-15 | — | — | EP | claimed |
| WO-2004009703-A1 | ANTISTATIC FLAME RETARDANT RESIN COMPOSITION AND METHODS FOR MANUFACTURE THEREOF | GENERAL ELECTRIC COMPANY (US) | 2004-01-29 | — | — | WO | claimed |
| US-20040011999-A1 | Antistatic flame retardant resin composition and methods for manufacture thereof | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2004-01-22 | — | — | US | claimed |
| US-6350804-B2 | POLYPHENYLENE ETHER RESIN AND BLENDS CONTAINING POLYPHENYLENE ETHER RESIN, AND AN ORGANOCLAY | GENERAL ELECTRIC CO. | 2002-02-26 | — | — | US | claimed |
| US-20010049025-A1 | Multilayer films having flame retardant layers | 3M INNOVATIVE PROPERTIES COMPANY | 2001-12-06 | — | — | US | claimed |
| US-20010031808-A1 | Polyphenylene ether resin concentrates containing organic phosphates | GENERAL ELECTRIC CO. | 2001-10-18 | — | — | US | claimed |
| US-6258879-B1 | Polyphenylene ether resin concentrates containing organic phosphates | GENERAL ELECTRIC COMPANY | 2001-07-10 | — | — | US | claimed |
| US-20260146128-A1 | POLYCARBONATE COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE POLYCARBONATE COMPOSITION | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2026-05-28 | — | — | US | disclosed |
| US-3953394-A | POLYETHYLENE TEREPHTHALATE-POLYBUTYLENE TEREPHTHALATE BLENDS | GENERAL ELECTRIC COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3943191-A | MOLDING | GENERAL ELECTRIC COMPANY (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146128-A1 | POLYCARBONATE COMPOSITION, METHOD FOR THE MANUFACTURE THEREOF, AND ARTICLES COMPRISING THE POLYCARBONATE COMPOSITION | CYP46A1, RPTOR, PCNA | CYP3A4 1415/4885L3MBTL1 1557/4885TSHR 3048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.